Simon Rule

96PUBLICATIONS

345CO-AUTHORS

Molecular targetsHaematological tumoursApplied statisticsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (96)

Sort by Publication Date:

|Jul 02, 2026

BRG1-mediated suppression of ferroptosis underlies BTK inhibitor resistance.

|Jul 01, 2026

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

|Jun 04, 2026

Five-year survival outcomes from TRANSCEND NHL 001 of lisocabtagene maraleucel in R/R LBCL.

|Apr 25, 2026

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

|Apr 21, 2026

Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study.

|Apr 18, 2026

Dissecting Pirtobrutinib Resistance in Mantle Cell Lymphoma Through Single-Cell Multi-Omics.

Pageof 16

Frequent Collaborators

19 joint publications

Preetesh Jain

10 joint publications

Sairah Ahmed

Jason Westin

Sattva S Neelapu

Yang Liu

Yucai Wang

Chi Young Ok

Holly Hill

Yixin Yao

Vivian Jiang

Frequent Collaborators

19 joint publications

Preetesh Jain

10 joint publications

Sairah Ahmed

9 joint publications

Jason Westin

8 joint publications

Sattva S Neelapu